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on the Vi antigen has been developed also against S. ryphi. Conjugate
vaccines are being tested against Salmonella and Shigella.
531 - Osteomyelitis
Mt~ Diagnosis and management of the infected joint
prosthesis
D. Osmon
Mayo Clinic, Rochester, Minnesota, United States
The risk ofprosthetic joint infection (I'JI) in the more than 430.000 total hip
and total knee arthroplasties performed in the United States each year is low
(1-4%). The incidence rate ofPJI is highest in the first two years following
prosthesis implantation. but has occurred as late as 20 years following
implantation. In the majority of cases. pJI is due to Sraphylococcus aureus,
coagulase negative staphylococci and B-hemolytic streptococci. Infections
due to other organisms occur much less frequently. Most infections arc
thought to occur as a consequence of intraoperative contamination of the
prosthesis. Hematogenous seeding uf the prosthesis is much less commun.
This talk will focus on the epidemiology. diagnosis. treatment and
prevention of pJI. Topics that will be discussed include new classification
schemes for I'JI, information regarding risk factors for I'JI. as well as selected
cuntroversies in the medical and surgical management of I'JI. These COI1-
truversies include the role of debridement and retention of the prosthesis.
given recent data regarding the treatment of staphylococcal I'JI without
prosthesis removal using antimicrobial combinations that include rifampin.
Lastly. strategies to prevent I'JI in the preoperative. intraoperative and
postoperative period will be reviewed. including a summary of new
consensus guidelines for the use of antibiotic prophylaxis to prevent PJI
due to ural flora following dental procedures.
IWeS40 I The use of quinolones and rifampin for the
treatment of infected orthopedic devices
W. Zimmerli. P. E. Ochsner
Medical University Clinic ami Orrhopedic Clinic, KatltotlSspital, Liestal,
Switzerland
Infections. mostly caused by Sraphylococcus aurel/s or coagulase-negative
staphylococci. arc feared complication in orthopedic surgery. Betalactams
are not a good choice for long-term oral treatment of device-related
infections, bCC'3USC of their lack of activity on sJow-groVY'ing bacteria, and
their unfavorable bioavailability. Therefore. the treatment with quinolone/
rifampin has been studied in patients with infected orthopedic devices. In
observational studies. the success-rate was 62% (13/21) (AAC 37: 1214.
1993). and 82% (9/11) (CID 14: 1251. 1992) with retention ofthe device. In a
randomized. placebo-controlled study comparing ciprofloxacin/rifampin vs
ciprofloxacin/placebo. the superiority of the rifampin-regimen has been
documented with cure-rates of 100% (12/12) vs 58% (7/12) (JAMA 279:
1537. 1998). Such high cure-rates can only be obtained. if patients are
carefully selected. Prerequisites for long-term (3-6 months) treatment with
retention of the device are as follows: (I) early manifestation « 3 months)
or hematogeneous infection with a short history « 1 month). (2) stable
implant. (3) rifampin- and quinolone-susceptible staphylococci. (4) good
condition of bone stock and soft tissue (no sinus tract). (5) debridement
surgery. In patients with sinus tracts. quinolone/rifampin treatment should
not be given. because of the risk of exogenous superinfection with quino-
lone/rifampin resistant microorganisms. Before the explantation of the
device. such patients should be treated with either flucloxacillin or a
glycopeptide, according to the susceptibility of the staphylococci. The
quinolone/rifampin regimen should be started only after reimplantation in
a 2-stage exchange. Long-term therapy with quinolone plus rifampin is
expensive and may cause adverse events (nausea. anorexia). Therefore. only
microbiologically documented cases should be treated with this regimen. In
conclusion. the quinolone/rifampin-regimen is higWy efficacious. ifpatients
are carefully selected.
IWeS411 The use of antibiotic-containing bead chains in the
treatment of chronic bone infections
K.Klemm
B.G. Unfallklinik FrankfUrt/Main, Cffmany
Objectives: By application of Gentamicin PMMA bead chains into osteo-
myelitic cavities a local antibiotic therapy in concentrations far above the
MIC of most common pathogens can be execuded.
Methods: The bone cement PMMA serves as carrier material for the
protracted release of the antibiotic. In in vitro studies of WaWig et al. up
to 600 JLg/ml were measured by elution in the buffer solution on the 1st day
and on the 80th day there were still 10 JLg/ml gentamicin per bead in the
eluate. Under clinical conditions 80 to 200 JLg/ml ofGentamicin were found
in the wound secretion depending on the number ofimplanted beads. With
such high concentrations at the infection site the MIC breakpoint of
Gentamicin 4 JLg/ml were exceeded locally by a factor of more than 10
whereas only low concentrations were found in the serum and urine.
Nephrotoxic and ototoxic side effects arc not to be feared.
Surgical procedure: After debridement of all infected and devitalized
tissue the infected cavity is filled completely with the Gentamicin PMMA
chains. For high local concentrations primary wound closure is dispensable.
The chains are removed by extraction within 7 days or when a second
operation as bone grafting is indicated
Results: In 405 cases of temporary filling ofosteomyelitis cavities presented
at the 13th. Int. Congress of Chemotherapy 1983 in Vienna the success rate
was 96%.
conclusion: Gentamicin PMMA chains are effective and save in the opera-
tive treatment of chronic osteomyelitis of all forms.
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IMoG2-11 Genetic markers: can molecular typing reveal an
epidemiological association?
M. C. J. Maiden
WeI/come Trl/st Centre for the Epidemiology of lrifectiol/s Disease. Department
of Zoology, University ofOxford, South Parks Road Oxford, United Kingdom
Bacterial epidemiology requires precise isolate characterisation. The tech-
niques used to achieve this should combine appropriate levels ofdiscrimina-
tion with cost effectiveness and reproducibility. Increasingly. serological
typing schemes are being replaced with molecu1ar techniques, which often
employ fingerprinting approaches. Unfortunately. many novel techniques
are of limited value because they fail to take into account the population
structure of the bacterial species under investigation. This talk will provide
an overview of bacterial population biology and describe how the insights
obtained from this subject can be exploited in the development ofeffective
isolate characterisation techniques and in the investigation of bacterial
epidemiology.
IMoG2-21 Evaluation of endemic nosocomial transmission
and sources of infection with the help of molecular typing
D. S. Blanc
Centre Hospitalier Universitaire Va'4dois, 1011 Lausanne, Switzerland
While molecular typing methods are widely used to help the hospital
epidemiologist in the investigation of nosocomial outbreaks, their use for
the understanding of endemic nosocomial infections has been limited. The
identification of the source or reservoir is only possible with comprehensive
screening of the environment and the endogenous flora ofpatients and staff.
and therefore requires significant resources. However. cross-eontarnination
or the existence of a common exogenous source might be investigated
typing clinical isolates during non epidemic periods. Cross-eontamination is
suspected when isolates from different patients belong to the same type and
when an epidemiological relation can be established. Studies performed with
the three main nosocomial pathogenes. StaphylococClls al/rel/S, Escherichia coli
and Pseudomonas aeruginosa, have revealed complex situations which may
vary from one setting to another. While some data suggest that pre-existing
colonization at admission is the major source ofmicroorganisms responsible
for nosocomial infections. other shows that exogenous sources or cross-
contamination may account for an important part of these infections.
According to these studies. the proportion of isolates presumably acquired
through cross-eontamination or exogenous source may vary from 10 to
60% for P. arfllgillosa and from 0 to 21 % for E. coli. The situation ofS. aureus
is complex because of the existence ofclones which may be higWy prevalent
in the population. with no apparent epidemiological link. Some data
suggest, that the proportion of cross-eontamination is lower for methicil1in
susceptible S. aI/tellS than for MRSA. This property for dissemination has
alsu been described ti" other multiresistant nosocomial pathugen•.
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Conclusion: Because molecular typing makes it possible to track the
dissemination of specific clones, it may facilitate the breaking down of
endemic transmission to the level of micro-epidemics.
IMoG2-311s multi-resistance an indicator of higher
transmissibility of nosocomial pathogens?
M. J. Struelens
Universite Libre de Bruxel/es, Hopital Erasme, Brussels, Belgium
A large number of molecular epidemiologic studies document the epidemic
spread of antibiotic-resistant clones of nosocomial pathogens within and
between hospitals. The pressure of intense antibiotic use in the hospital
patient population confers a selective advantage to resistant clones which are
more likely to survive and multiply to replace the antibiotic susceptible
commensal tlora. Examples ofepidemic antibiotic resistant clones associated
with large scale epidemics which can lead to a net excess of nosocomial
infection by that species include methicillin-resistant Staphylococcus aureus,
clindamycin-resistant Clostridium dijJicile, multi-drug resistant A&inetobacter
baumannii. Klebsiella pneumoniae. Enterobacter aerogenes and Burkholderia
cepacia. Less information is available regarding the hypothesis that successful
antibiotic resistant clones carry additional virulence determinants enhancing
their transmissibility and/or pathogenicity. This type ofassociation has been
found among epidemic types of Klebsiella pneumoniae, carrying large
plasmids encoding multi-drug resistance (extended spectrum beta-Iaeta-
mase, aminoglycoside modifying enzymes) aerobaerin and an adhesin
promoting colonization of intestinal epithelium. Likewise, a pandemic
electrophoretype 12 of Burkholderia cepacia associated with nosocomial
outbreaks in cystic fibrosis patients harbours a specific gene coding for the
cblA pilin subunit and a conserved IS element which may promote genomic
rearrangements involved in resistance or transmissibility. Whereas multi-
resistance is often an indicator of epidemicity for nosocomial pathogens,
more studies are needed to determine genetic and functional determinants of
enhanced transmissibility ofepidemic clones beyond the seleerive advantage
of resistance. Identification of such markers would be useful to predier the
epidemic potential ofclinical isolates and respond accordingly with infection
control measures.
IMoG2-SI What tools do we need to understand the
dynamics of hospital acquired infections in places like intensive
care units?
H:ajo Grund.tna.nn
Noltingham. United Kingdom University
Molecular typing provides infection control personnel with a wealth ofdata
pertaining to the population structure ofthe pathogens that are isolated from
patients. Since hospital epidemiologists are conventionally more interested
in the population of hosts than in that of the pathogens routine typing data
are usually not exploited to their fuJI potential. Using this data for the
analysis of time space interaction by genotype may lead to the identification
of miniclusters that occur above a certain level of expeerancy. A couple of
statistical tests can be employed to that end. Another way ofutilising typing
data introduces differential risk faeror analysis which may include some
classical case control or cohort approaches. In typically endemic situations i.e
in the absence of outbreaks, hidden transmission dynamics may thus be
revealed and the success ofpreventive measures may be predicted by simple
stochastic models.
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IMoG3-11 Diagnosis and prevention of surgical site infections:
Problems with definitions
R. C. Spencer
Public Health Laboratory, Bristol BS2 8HW. United Kingdom
Surveillance studies require careful planning with a clear protocol, but,
above all, they need accepted definitions. No single set ofdefinitions has been
universally adopted, although there is a generally agreed-upon group of
ideas or problems central to the issue. A variety ofdefinitions ofnosocomial
infections have been proposed and used in hospital surveiJlance studies. Some
reports have proposed very simple definitions, while others have produced
much more detailed ones. Even when epidemiologists, nurses and clinical
microbiologists have produced consensus definitions, some health-care
workers stiJl find problems in their interpretation. There is no doubting
that variations in defmitions can influence the recorded rate ofinfection and
without definitive definitions, comparisons between hospitals are mean-
ingless. Unfortunately many individual institutions modify these consensus
definitions to suit their own particular resident populations and doctor/
laboratory facilities and availability. Indeed, some authors recommend that
this should happen. Whichever defmitions are used, microbiological and
imaging findings should be used only to confirm clinical evidence of
infection. It is strongly recommended that aJl professional as.sociations of
those health-eare workers involved in the surveillance of nosocomial
infections should co-operate to develop standardised case definitions suitable
for routine use. A plea is made for simplicity and clarity. It remains essential
that such case defmitions for surveillance purposes ensure a high level of
sensitivity in order to allow the earliest detection of infective nosocomial
problems.
IMoG3-21 Nosocomial aspergillosis: Are there effective
measures for prevention
Patricia Munoz
Hospilal Gtneral Universilario "Gregorio Marmion". Madrid, Spain
Aspergillosis is the second most common nosocomial mycosis. Recommen-
dations to prevent aspergillosis in high-risk patients include the reduction of
environmental exposure and the recognition of predisposing faerors and
periods ofincreased risk The strict observation ofinfection control measures
(air quality, isolation of construction works) in centers with immunocom-
promised patients is essential. Environmental protection trying to insure that
the air of selected units is free from Aspergillus spores is the most important
step of prophylaxis, although it is not always possible. Constant environ-
mental surveillance is a difficult goal and exposure may occur at other sites of
the hospital or in the community. The prompt recognition ofnosocomia1
cases is also recommended. The reduction of predisposing factors in high-
risk patients may include the prevention and adequate management of
neutropenia and rejection episodes, the prevention of infections such as
CMV. HHV-6 or relapsing HCV and the judicious use of Immuno
suppressive therapy. Targeted surveillance cultures and primary prophylaxis
against invasive aspergillosis are not standard measures in solid organ
transplant recipients although they are more commouly used for neutro-
penic patients. The current lack of reliable preventive regimens against
aspergillosis and against emerging resistant fungal pathogens presents an
ongoing challenge. New antifungal agents, such as triazoles and new AMB
presentations. have proved to be u..,ful in some recent studies.
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IMoG4-1 [ Non-invasive tests for the diagnosis of Hellcobacter
pylori infection
H. Rautelin
Department ofBacteriology and Immunology, Haartman Institute, University of
Helsinki, and Helsinki U"iversity Central Hospital Laboratory Diagnostics,
Helsinki, Finland
Non-invasive (gastroscopy not needed) diagnosis of H. pylori infection
includes in practice detection of H. pylori antibodies, urea breath tests, and
a recently developed test detecting H. pylori antigen in stool. In the primary
diagnosis of H. pylori infection, non-invasive diagnostic methods may be
used solely in younger patients who are not endoscopied. Among patients
endoscopied, non-invasive diagnostic methods are useful in addition to
invasive tests. For instance in atrophic gastritis, invasive diagnostic methods,
and even urea breath test, may fail in showing H. pylori probably due to the
low number of bacteria present. However, elevated antibody titres of H.
pylori may still indicate the infection in these cases. In general, no single test is
optimal in the diagnosis of H. pylori infection but the best test(s) in each
clinical setting may be chosen if the advantages and restrictions of the
different tests are known. AJI diagnostic tests should be validated locaJly. As
the prevalence of H. pylori infection is rapidly decreasing in developed
coumries, the positive predictive value of the test might be very different
from that in a high prevalence population.
In contrast to biopsy-based tests, non-invasive diagnostic methods may
also be used for the foJlow-up oferadication therapy; urea breath test as early
as 4 weeks and quantitative serology 4-6 months after the therapy. If
serology is used for the foJlow-up, pre-treatmcm serum sample must be.
